Journey Medical Corp (DERM)
4.10 -0.06 (-1.44%) 11:20 ET [NASDAQ]
4.10 x 500 4.22 x 200
Realtime by (Cboe BZX)
4.10 x 500 4.22 x 200
Realtime 4.17 +0.01 (+0.24%) 08:48 ET
for Mon, Jan 27th, 2025
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | -221,540 | -303,261 | -89,084 | -78,399 | -31,875 |
Depreciation Amortization | 80 | 2,705 | 2,002 | 2,084 | 254 |
Accounts payable and accrued liabilities | 823 | 1,542 | 4,266 | 3,607 | 3,209 |
Other Working Capital | -30,209 | 44,063 | 515 | 20,223 | -1,511 |
Other Operating Activity | 37,748 | 150,988 | 8,190 | 4,043 | -1,481 |
Operating Cash Flow | $-213,098 | $-103,963 | $-74,111 | $-48,442 | $-31,404 |
Cash Flows From Investing Activities | |||||
PPE Investments | -616 | -278 | -753 | -202 | -156 |
Purchase Of Investment | -319,940 | -302,432 | -252,175 | -60,276 | -109,324 |
Sale Of Investment | 363,328 | 278,580 | 122,640 | 57,875 | N/A |
Other Investing Activity | -56,000 | -80,000 | 0 | 0 | 0 |
Investing Cash Flow | $-13,228 | $-104,130 | $-130,288 | $-2,603 | $-109,480 |
Cash Flows From Financing Activities | |||||
Debt Issued | 33,235 | 278,246 | N/A | N/A | N/A |
Debt Repayment | N/A | N/A | N/A | -2,120 | N/A |
Common Stock Issued | 2,146 | 184,277 | 138,950 | 105,049 | 120,273 |
Other Financing Activity | 0 | 0 | 0 | 0 | 53,825 |
Financing Cash Flow | $35,381 | $462,523 | $138,950 | $102,929 | $174,098 |
Beginning Cash Position | 296,723 | 42,293 | 107,742 | 55,358 | 22,144 |
End Cash Position | 105,778 | 296,723 | 42,293 | 107,242 | 55,358 |
Net Cash Flow | $-190,945 | $254,430 | $-65,449 | $51,884 | $33,214 |
Free Cash Flow | |||||
Operating Cash Flow | -213,098 | -103,963 | -74,111 | -48,442 | -31,404 |
Capital Expenditure | -616 | -278 | -753 | -202 | -156 |
Free Cash Flow | -213,714 | -104,241 | -74,864 | -48,644 | -31,560 |